Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × Capecitabine × Clear all

NCT02595424 2025-12-29

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Phase 2 Active not recruiting

Somatostatinoma, Carcinoma, Neuroendocrine

NCT03387592 2025-03-10

SENECA

Phase 2 Terminated

Carcinoma, Neuroendocrine

NCT03079440 2022-12-06

TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors

Phase 2 Completed

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01203306 2010-09-16

XELBEVOCT

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors